Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight.

Dombi E, Solomon J, Gillespie AJ, Fox E, Balis FM, Patronas N, Korf BR, Babovic-Vuksanovic D, Packer RJ, Belasco J, Goldman S, Jakacki R, Kieran M, Steinberg SM, Widemann BC.

Neurology. 2007 Feb 27;68(9):643-7. Epub 2007 Jan 10.

PMID:
17215493
2.

Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.

Widemann BC, Babovic-Vuksanovic D, Dombi E, Wolters PL, Goldman S, Martin S, Goodwin A, Goodspeed W, Kieran MW, Cohen B, Blaney SM, King A, Solomon J, Patronas N, Balis FM, Fox E, Steinberg SM, Packer RJ.

Pediatr Blood Cancer. 2014 Sep;61(9):1598-602. doi: 10.1002/pbc.25041. Epub 2014 Apr 22.

PMID:
24753394
3.

Tumor burden evaluation in NF1 patients with plexiform neurofibromas in daily clinical practice.

Pratt L, Helfer D, Weizman L, Shofty B, Constantini S, Joskowicz L, Ben Bashat D, Ben-Sira L.

Acta Neurochir (Wien). 2015 May;157(5):855-61. doi: 10.1007/s00701-015-2366-z. Epub 2015 Mar 14. Erratum in: Acta Neurochir (Wien). 2015 Jun;157(6):1091.

PMID:
25772343
4.

Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits.

Nguyen R, Kluwe L, Fuensterer C, Kentsch M, Friedrich RE, Mautner VF.

J Pediatr. 2011 Oct;159(4):652-5.e2. doi: 10.1016/j.jpeds.2011.04.008. Epub 2011 May 31.

PMID:
21621223
5.

Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas.

Tucker T, Friedman JM, Friedrich RE, Wenzel R, F√ľnsterer C, Mautner VF.

J Med Genet. 2009 Feb;46(2):81-5. doi: 10.1136/jmg.2008.061051. Epub 2008 Oct 17.

PMID:
18930997
6.

Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas.

Kim A, Gillespie A, Dombi E, Goodwin A, Goodspeed W, Fox E, Balis FM, Widemann BC.

Neurology. 2009 Oct 20;73(16):1273-9. doi: 10.1212/WNL.0b013e3181bd1326.

7.

Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromas.

Avery RA, Dombi E, Hutcheson KA, Acosta MT, Baldwin AM, Madigan WP, Gillespie A, Fitzgibbon EJ, Packer RJ, Widemann BC.

Am J Ophthalmol. 2013 Jun;155(6):1089-1094.e1. doi: 10.1016/j.ajo.2013.01.011. Epub 2013 Feb 26.

PMID:
23453281
8.

Quantitative associations of scalp and body subcutaneous neurofibromas with internal plexiform tumors in neurofibromatosis 1.

Jett K, Nguyen R, Arman D, Birch P, Chohan H, Farschtschi S, Fuensterer C, Kluwe L, Friedman JM, Mautner VF.

Am J Med Genet A. 2015 Jul;167(7):1518-24. doi: 10.1002/ajmg.a.37068. Epub 2015 Apr 21.

PMID:
25900062
9.

Interactive segmentation of plexiform neurofibroma tissue: method and preliminary performance evaluation.

Weizman L, Hoch L, Ben Bashat D, Joskowicz L, Pratt LT, Constantini S, Ben Sira L.

Med Biol Eng Comput. 2012 Aug;50(8):877-84. doi: 10.1007/s11517-012-0929-1. Epub 2012 Jun 16.

PMID:
22707229
10.

Automated detection and volume measurement of plexiform neurofibromas in neurofibromatosis 1 using magnetic resonance imaging.

Solomon J, Warren K, Dombi E, Patronas N, Widemann B.

Comput Med Imaging Graph. 2004 Jul;28(5):257-65.

PMID:
15249071
11.

Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1.

Nguyen R, Dombi E, Widemann BC, Solomon J, Fuensterer C, Kluwe L, Friedman JM, Mautner VF.

Orphanet J Rare Dis. 2012 Oct 4;7:75. doi: 10.1186/1750-1172-7-75.

12.

Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.

Widemann BC, Dombi E, Gillespie A, Wolters PL, Belasco J, Goldman S, Korf BR, Solomon J, Martin S, Salzer W, Fox E, Patronas N, Kieran MW, Perentesis JP, Reddy A, Wright JJ, Kim A, Steinberg SM, Balis FM.

Neuro Oncol. 2014 May;16(5):707-18. doi: 10.1093/neuonc/nou004. Epub 2014 Feb 4.

13.

Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.

Robertson KA, Nalepa G, Yang FC, Bowers DC, Ho CY, Hutchins GD, Croop JM, Vik TA, Denne SC, Parada LF, Hingtgen CM, Walsh LE, Yu M, Pradhan KR, Edwards-Brown MK, Cohen MD, Fletcher JW, Travers JB, Staser KW, Lee MW, Sherman MR, Davis CJ, Miller LC, Ingram DA, Clapp DW.

Lancet Oncol. 2012 Dec;13(12):1218-24. doi: 10.1016/S1470-2045(12)70414-X. Epub 2012 Oct 23.

14.

MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1.

Mautner VF, Hartmann M, Kluwe L, Friedrich RE, F√ľnsterer C.

Neuroradiology. 2006 Mar;48(3):160-5. Epub 2006 Jan 24.

PMID:
16432718
15.

Growth behavior of plexiform neurofibromas after surgery.

Nguyen R, Ibrahim C, Friedrich RE, Westphal M, Schuhmann M, Mautner VF.

Genet Med. 2013 Sep;15(9):691-7. doi: 10.1038/gim.2013.30. Epub 2013 Apr 18.

PMID:
23598713
16.

Superficial neurofibroma: a lesion with unique MRI characteristics in patients with neurofibromatosis type 1.

Lim R, Jaramillo D, Poussaint TY, Chang Y, Korf B.

AJR Am J Roentgenol. 2005 Mar;184(3):962-8.

PMID:
15728625
17.

Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study.

Weiss B, Widemann BC, Wolters P, Dombi E, Vinks A, Cantor A, Perentesis J, Schorry E, Ullrich N, Gutmann DH, Tonsgard J, Viskochil D, Korf B, Packer RJ, Fisher MJ.

Neuro Oncol. 2015 Apr;17(4):596-603. doi: 10.1093/neuonc/nou235. Epub 2014 Oct 14. Erratum in: Neuro Oncol. 2015 Jun;17(6):905.

18.

18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST).

Meany H, Dombi E, Reynolds J, Whatley M, Kurwa A, Tsokos M, Salzer W, Gillespie A, Baldwin A, Derdak J, Widemann B.

Pediatr Blood Cancer. 2013 Jan;60(1):59-64. doi: 10.1002/pbc.24212. Epub 2012 May 29.

PMID:
22645095
19.

Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.

Waggoner DJ, Towbin J, Gottesman G, Gutmann DH.

Am J Med Genet. 2000 May 15;92(2):132-5.

PMID:
10797438
20.

Response of NF1-related plexiform neurofibroma to high-dose carboplatin.

Hummel T, Anyane-Yeboa A, Mo J, Towbin A, Weiss B.

Pediatr Blood Cancer. 2011 Mar;56(3):488-90. doi: 10.1002/pbc.22827. Epub 2010 Nov 11.

PMID:
21225936

Supplemental Content

Support Center